Table 1.
Assessing mortality risk of study groups from COVID-19 by univariate and multivariate statistical analysis.
| Outcome: Mortality | Univariate | Multivariate Binary Logistic Regression |
|||||
|---|---|---|---|---|---|---|---|
| Yes (%) | Sig. | OR with 95% CI | RR with 95% CI | Sig. | aOR with 95% CI | ||
| Sex (M/F) | M: F: |
140 (31.3) 49 (15.7) |
<0.001 (C) | 2.44 (1.69–3.51) | 1.99 (1.49–2.66) | <0.001 (C) | 2.59 (1.73–3.90) |
| Age (median, IQR) | Dead: 73 (16) Alive: 62 (23) |
<0.001 (M–W) | - | - | <0.001 (C) | 1.049 (1.031–1.066) | |
| β-Thalassemia heterozygosity | Yes: No: |
53 (38.7) 136 (21.8) |
<0.001 (C) | 2.26 (1.53–3.35) | 1.77 (1.37–2.29) | 0.001 | 2.41 (1.55–3.74) |
| Chronic respiratory disease | Yes: No: |
41 (43.6) 148 (22.2) |
<0.001 (C) | 2.71 (1.73–4.23) | 1.96 (1.50–2.57) | 0.018 | 1.84 (1.11–3.05) |
| Atrial fibrillation | Yes: No: |
84 (37.0) 103 (19.4) |
<0.001 (C) | 2.44 (1.73–3.45) | 1.91 (1.50–2.43) | 0.058 | 1.50 (0.99– 2.28) |
| Hypertension | Yes: No: |
138 (32.9) 51 (15.0) |
<0.001 (C) | 2.77 (1.93–3.98) | 2.19 (1.64–2.92) | 0.243 | 1.31 (0.83–2.04) |
| Coronary disease | Yes: No: |
53 (37.3) 136 (22.0) |
<0.001 (C) | 2.11 (1.43–3.12) | 1.70 (1.31–2.20) | 0.617 | 0.89 (0.55–1.42) |
| Diabetes mellitus type II | Yes: No: |
48 (30.8) 141 (23.3) |
0.056 (C) | 1.46 (0.99–2.15) | 1.32 (1.00–1.74) | 0.439 | 0.84 (0.54–1.30) |
| Neoplasia | Yes: No: |
27 (31.8) 162 (24.1) |
0.122 (C) | 1.47 (0.90–2.40) | 1.32 (0.94–1.85) | 0.653 | 0.88 (0.52–1.51) |
C, Chi-square test; F, Fisher’s exact test; M–W, Mann–Whitney U test.